Humacyte

PriceHumacyte

HUMA

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

Historical stock price chart and annual return over the past years

-85%

4 years

% Total

HUMA
-32%

4 years

Annual Return

HUMA